These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31619404)

  • 1. The Association between the Comprehensive Epstein-Barr Virus Serologic Profile and Endemic Burkitt Lymphoma.
    Coghill AE; Proietti C; Liu Z; Krause L; Bethony J; Prokunina-Olsson L; Obajemu A; Nkrumah F; Biggar RJ; Bhatia K; Hildesheim A; Doolan DL; Mbulaiteye SM
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):57-62. PubMed ID: 31619404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus Genomes Reveal Population Structure and Type 1 Association with Endemic Burkitt Lymphoma.
    Kaymaz Y; Oduor CI; Aydemir O; Luftig MA; Otieno JA; Ong'echa JM; Bailey JA; Moormann AM
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection.
    Bhaduri-McIntosh S; Landry ML; Nikiforow S; Rotenberg M; El-Guindy A; Miller G
    J Infect Dis; 2007 Feb; 195(4):483-92. PubMed ID: 17230407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma.
    Piriou E; Asito AS; Sumba PO; Fiore N; Middeldorp JM; Moormann AM; Ploutz-Snyder R; Rochford R
    J Infect Dis; 2012 Mar; 205(6):906-13. PubMed ID: 22301635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Antibodies against Epstein-Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric Cancer.
    Camargo MC; Kim KM; Matsuo K; Torres J; Liao LM; Morgan D; Michel A; Waterboer T; Song M; Gulley ML; Dominguez RL; Yatabe Y; Kim S; Cortes-Martinez G; Lissowska J; Zabaleta J; Pawlita M; Rabkin CS
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):414-419. PubMed ID: 31719065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral response to chemotherapy in endemic burkitt lymphoma.
    Tang W; Harmon P; Gulley ML; Mwansambo C; Kazembe PN; Martinson F; Wokocha C; Kenney SC; Hoffman I; Sigel C; Maygarden S; Hoffman M; Shores C
    Clin Cancer Res; 2010 Apr; 16(7):2055-64. PubMed ID: 20233888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma magnesium is inversely associated with Epstein-Barr virus load in peripheral blood and Burkitt lymphoma in Uganda.
    Ravell J; Otim I; Nabalende H; Legason ID; Reynolds SJ; Ogwang MD; Ndugwa CM; Marshall V; Whitby D; Goedert JJ; Engels EA; Bhatia K; Lenardo MJ; Mbulaiteye SM
    Cancer Epidemiol; 2018 Feb; 52():70-74. PubMed ID: 29248801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus viral load and serology in childhood non-Hodgkin's lymphoma and chronic inflammatory conditions in Uganda: implications for disease risk and characteristics.
    Orem J; Sandin S; Mbidde E; Mangen FW; Middeldorp J; Weiderpass E
    J Med Virol; 2014 Oct; 86(10):1796-803. PubMed ID: 24889739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the Epstein-Barr Virus gp350 IgA Antibody Response Are Associated With Increased Risk for Coinfection With a Second Strain of Epstein-Barr Virus.
    Smith NA; Baresel PC; Jackson CL; Ogolla S; Toko EN; Heit S; Piriou E; Sumba OP; Middeldorp JM; Colborn KL; Rochford R
    J Infect Dis; 2019 Feb; 219(6):955-963. PubMed ID: 30312417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus and risk of non-Hodgkin lymphoma in the cancer prevention study-II and a meta-analysis of serologic studies.
    Teras LR; Rollison DE; Pawlita M; Michel A; Brozy J; de Sanjose S; Blase JL; Gapstur SM
    Int J Cancer; 2015 Jan; 136(1):108-16. PubMed ID: 24831943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren's Syndrome.
    Xuan J; Ji Z; Wang B; Zeng X; Chen R; He Y; Rao P; Wu P; Shi G
    Front Immunol; 2020; 11():590444. PubMed ID: 33193425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies.
    Argirion I; Pfeiffer RM; Proietti C; Coghill AE; Yu KJ; Middeldorp JM; Sarathkumara YD; Hsu WL; Chien YC; Lou PJ; Wang CP; Rothman N; Lan Q; Chen CJ; Mbulaiteye SM; Jarrett RF; Glimelius I; Smedby KE; Hjalgrim H; Hildesheim A; Doolan DL; Liu Z
    Cancer Epidemiol Biomarkers Prev; 2023 May; 32(5):687-696. PubMed ID: 36788424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong correlations of anti-viral capsid antigen antibody levels in first-degree relatives from families with Epstein-Barr virus-related lymphomas.
    Besson C; Amiel C; Le-Pendeven C; Plancoulaine S; Bonnardel C; Ranque B; Abbed K; Brice P; Fermé C; Carde P; Hermine O; Raphael M; Bresson JL; Nicolas JC; Gessain A; Dethe G; Abel L
    J Infect Dis; 2009 Apr; 199(8):1121-7. PubMed ID: 19284285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early stage of Epstein-Barr virus lytic infection leading to the "starry sky" pattern formation in endemic Burkitt lymphoma.
    Fujita S; Buziba N; Kumatori A; Senba M; Yamaguchi A; Toriyama K
    Arch Pathol Lab Med; 2004 May; 128(5):549-52. PubMed ID: 15086279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of primary Epstein-Barr virus infection disease spectrum and its reactivation in children, in Suzhou, China.
    Shi T; Huang L; Chen Z; Tian J
    J Med Virol; 2021 Aug; 93(8):5048-5057. PubMed ID: 33719067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
    Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P
    J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling of EBV Infection and Antibody Responses in Kenyan Infants With Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection.
    Reynaldi A; Schlub TE; Piriou E; Ogolla S; Sumba OP; Moormann AM; Rochford R; Davenport MP
    J Infect Dis; 2016 Nov; 214(9):1390-1398. PubMed ID: 27571902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma.
    Liu Z; Sarathkumara YD; Chan JKC; Kwong YL; Lam TH; Ip DKM; Chiu BC; Xu J; Su YC; Proietti C; Cooper MM; Yu KJ; Bassig B; Liang R; Hu W; Ji BT; Coghill AE; Pfeiffer RM; Hildesheim A; Rothman N; Doolan DL; Lan Q
    Sci Rep; 2021 Dec; 11(1):23664. PubMed ID: 34880297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
    Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
    PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.